Therapeutic Pipeline Program

the Therapeutic Pipeline Program supports Parkinson's disease therapeutic development along the pre-clinical and clinical path (both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches). Application should be relevant to: 

• Disease-modifying strategies
• Symptomatic strategies
• Applied Technologies as Treatments for Parkinson’s

Funding: $500,000 (for pre clinical research) 

Duration: 2 years 

Research Authority due date: 11.4.19

Pre proposal (required) due date:  19.4.19

Full application due date: 19.7.19